Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
---|---|---|---|---|---|---|
2012 | Safety issues of long-term glucose load in patients on peritoneal dialysis-A 7-year cohort study | Wu H.-Y.; KUAN-YU HUNG ; TAO-MIN HUANG ; Hu F.-C.; Peng Y.-S.; JENQ-WEN HUANG ; SHUEI-LIONG LIN ; YUNG-MING CHEN ; TZONG-SHINN CHU ; TUN-JUN TSAI ; KWAN-DUN WU | PLoS ONE | 39 | 34 | |
2009 | Safety of fluoroquinolone use in patients with hepatotoxicity induced by anti-tuberculosis regimens | CHAO-CHI HO ; YEE-CHUN CHEN ; Hu F.-C.; CHONG-JEN YU ; PAN-CHYR YANG ; KWEN-TAY LUH | Clinical Infectious Diseases | 44 | 35 | |
2008 | SAPS 3 at dialysis commencement is predictive of hospital mortality in patients supported by extracorporeal membrane oxygenation and acute dialysis | Tsai C.-W.; YU-FENG LIN ; VIN-CENT WU ; TZONG-SHINN CHU ; YUNG-MING CHEN ; Hu F.-C.; KWAN-DUN WU ; Ko W.-J. | European Journal of Cardio-thoracic Surgery | 19 | 19 | |
2011 | Secular trend of the viral genotype distribution in children with chronic hepatitis B virus infection after universal infant immunization | Wen W.-H.; HUEY-LING CHEN ; YEN-HSUAN NI ; HONG-YUAN HSU ; JIA-HORNG KAO ; Hu F.-C.; MEI-HWEI CHANG | Hepatology | 57 | 56 | |
2015 | Sequence variants of peroxisome proliferator-activated receptor-gamma gene and the clinical courses of patients with end-stage renal disease | CHIA-TER CHAO ; YEN-CHING CHEN ; CHIH-KANG CHIANG ; JENQ-WEN HUANG ; Hu F.-C.; CHENG-CHUNG FANG ; Chang C.-C.; CHUNG-JEN YEN | Disease Markers | 8 | 5 | |
2010 | Significance of Aurora B overexpression in hepatocellular carcinoma. Aurora B Overexpression in HCC | ZHONG-ZHE LIN ; YUNG-MING JENG ; Hu F.-C.; Pan H.-W.; Tsao H.-W.; Lai P.; PO-HUANG LEE ; ANN-LII CHENG ; Hsu H.-C. | BMC Cancer | 101 | 98 | |
2011 | Soluble triggering receptor expressed on myeloid cells-1 as an infection marker for patients with neutropenic fever | Lin C.-H.; MING YAO ; SZU-CHUN HSU ; CHAO-CHI HO ; Lin M.-T.; Lin C.-A.; Hu F.-C.; CHONG-JEN YU ; HWEI-FANG TIEN | Critical Care Medicine | 7 | 9 | |
2008 | Specific EGFR mutations predict treatment outcome of stage IIIB/IV patients with chemotherapy-naive non-small-cell lung cancer receiving first-line gefitinib monotherapy | CHIH-HSIN YANG ; CHONG-JEN YU ; JIN-YUAN SHIH ; YEUN-CHUNG CHANG ; Hu F.-C.; Tsai M.-C.; KUAN-YU CHEN ; ZHONG-ZHE LIN ; Huang C.-J.; CHIA-TUNG SHUN ; Huang C.-L.; Bean J.; ANN-LII CHENG ; Pao W.; PAN-CHYR YANG | Journal of Clinical Oncology | 240 | 224 | |
2013 | Survival of septic adults compared with nonseptic adults receiving extracorporeal membrane oxygenation for cardiopulmonary failure: A propensity-matched analysis | ARISTINE CHENG ; HSIN-YUN SUN ; Lee C.-W.; Ko W.-J.; Tsai P.-R.; YU-CHUNG CHUANG ; Hu F.-C.; SHAN-CHWEN CHANG ; YEE-CHUN CHEN | Journal of Critical Care | 34 | 30 | |
2010 | Sustained low-efficiency dialysis versus continuous veno-venous hemofiltration for postsurgical acute renal failure | VIN-CENT WU ; CHIH-HSIEN WANG ; Wang W.-J.; YU-FENG LIN ; Hu F.-C.; Chen Y.-W.; YIH-SHARNG CHEN ; MING-SHIOU WU ; YEN-HUNG LIN ; Kuo C.-C.; TAO-MIN HUANG ; YUNG-MING CHEN ; Tsai P.-R.; Ko W.-J.; KWAN-DUN WU | American Journal of Surgery | 46 | 40 | |
2021 | Taiwan mini-frontier of primary aldosteronism: Updating treatment and comorbidities detection | CHIEH-KAI CHAN ; Chang, Yi-Yao; Tsai, Yi-Chun; ZHENG-WEI CHEN ; Wu, Chun-Yi; Huang, Wei-Chieh; Yen, I-Weng; Wu, Kuo-Hsin; VIN-CENT WU ; YEN-HUNG LIN ; SHUO-MENG WANG ; Wang W.-J.; Wu C.-H.; Hu Y.-H.; Er L.K.; Chang C.-H.; Tsai Y.-C.; Yu C.-C.; LIAN-YU LIN ; Hu F.-C.; CHIN-CHEN CHANG ; KAO-LANG LIU ; Wang S.-M.; KUO-HOW HUANG ; SHIH-CHIEH CHUEH ; SHIH-CHENG LIAO ; CHING-CHU LU ; RUOH-FANG YEN ; KWAN-DUN WU ; TAIPAI Study Group | Journal of the Formosan Medical Association = Taiwan yi zhi | 4 | 3 | |
2019 | Targeted treatment of primary aldosteronism – The consensus of Taiwan Society of Aldosteronism | KUO-HOW HUANG ; Yu C.-C.; Hu Y.-H.; CHIN-CHEN CHANG ; CHIEH-KAI CHAN ; Shih-Cheng Liao ; Tsai Y.-C.; SHIH-CHIEH CHUEH ; VIN-CENT WU ; YEN-HUNG LIN ; Lin J.-H.; Wang W.-J.; Wu C.-H.; Er L.-K.; Chang C.-H.; Chang Y.-L.; YI-LWUN HO ; Chang H.-W.; LIAN-YU LIN ; Hu F.-C.; KAO-LANG LIU ; SHUO-MENG WANG ; CHING-CHU LU ; RUOH-FANG YEN ; KWAN-DUN WU ; TAIPAI, Taiwan Primary Aldosteronism Investigator | Journal of the Formosan Medical Association | 21 | 18 | |
2015 | TP53 Mutational Analysis Enhances the Prognostic Accuracy of IHC4 and PAM50 Assays | CHING-HUNG LIN ; Chen I.-C.; CHIUN-SHENG HUANG ; Hu F.-C.; WEN-HUNG KUO ; KUAN-TING KUO ; Wang C.-C.; Wu P.-F.; DWANG-YING CHANG ; Wang M.-Y.; Chang C.-H.; WEI-WU CHEN ; YEN-SHEN LU ; ANN-LII CHENG | Scientific Reports | 10 | 11 | |
2015 | The value of losartan suppression test in the confirmatory diagnosis of primary aldosteronism in patients over 50 years old | Kuo C.-C.; Balakrishnan P.; Hsein Y.-C.; VIN-CENT WU ; SHIH-CHIEH CHUEH ; YUNG-MING CHEN ; KWAN-DUN WU ; MING-JIUH WANG ; YEN-HUNG LIN ; YI-LWUN HO ; Chang H.-W.; LIAN-YU LIN ; Hu F.-C.; KAO-LANG LIU ; SHUO-MENG WANG ; KUO-HOW HUANG ; CHIN-CHEN CHANG ; CHING-CHU LU ; Shih-Cheng Liao ; RUOH-FANG YEN ; WEI-CHOU LIN ; Hsieh, Bor-Sen; TAIPAI group | JRAAS - Journal of the Renin-Angiotensin-Aldosterone System | 9 | 6 | |
2009 | Variants in the UGT1A1 gene and the risk of pediatric nonalcoholic fatty liver disease | Lin Y.-C.; Chang P.-F.; Hu F.-C.; MEI-HWEI CHANG ; YEN-HSUAN NI | Pediatrics | 57 | 51 |